Quick Comparison Overview
| Feature | Semaglutide | Retatrutide |
|---|---|---|
| Mechanism | GLP-1 agonist | GLP-1/GIP/GCGR triple agonist |
| Research Stage | Extensively studied, approved drug | Emerging, Phase 3 trials |
| Preclinical weight loss | 10–15% | 20–25% |
| Dosing frequency | Once weekly | Once weekly |
| Typical price (5mg) | €70 | €75 |
Mechanism of Action
Semaglutide: GLP-1 Agonist
Activates GLP-1 receptors exclusively. Enhances glucose-dependent insulin secretion, suppresses glucagon, slows gastric emptying, and reduces appetite via central mechanisms. Ideal for clean, single-pathway GLP-1 research.
Retatrutide: Triple Agonist
Simultaneously activates GLP-1, GIP, and glucagon receptors. Synergistic metabolic effects: enhanced insulin secretion, increased energy expenditure (glucagon), superior appetite suppression, improved lipid metabolism. Best for comprehensive metabolic studies.
Efficacy: Research Data
Published preclinical research demonstrates:
- Semaglutide: 10–15% body weight reduction in rodent models at optimal dosing
- Retatrutide: 20–25% body weight reduction in comparable models — nearly double the effect
Phase 2 clinical data (for reference) showed retatrutide produced significantly greater effects across all metabolic endpoints, validating the mechanistic advantages observed in preclinical models.
Dosing Protocols
Semaglutide Research Dosing
| Phase | Typical Dose |
|---|---|
| Weeks 1–4 | 0.25 mg |
| Weeks 5–8 | 0.5 mg |
| Week 9+ | 1–2.4 mg |
Retatrutide Research Dosing
| Phase | Typical Dose |
|---|---|
| Weeks 1–4 | 2–4 mg |
| Weeks 5–8 | 4–8 mg |
| Week 9+ | 8–12 mg |
When to Choose Each Peptide
Choose Semaglutide When:
- Research specifically investigates GLP-1 receptor biology
- You need to replicate established published protocols
- Running comparative studies using a well-characterized baseline
- Budget is a primary consideration
Choose Retatrutide When:
- Studying multiple interconnected metabolic pathways
- Investigating synergistic receptor interactions
- Requiring maximum efficacy in metabolic intervention models
- Glucagon receptor activation is relevant to your research question
Order Both Peptides — Ships Across Europe
Semaglutide €70 · Retatrutide €75 · ≥98% purity · COA included
Shop Now →